Academic anti CD19 CAR-T cell therapy for relapsed/refractory B-cell lymphomas in real-world clinical practice: a prospective cohort study.

Konoplya NE, Doroshenko TM, Zharkova KY, Savich TV, Seviaryn IM, Bobrova NM, Beleevsky AA, Sarydze EK, Polyakov SL

Open source

DOI: 10.3389/fonc.2026.1862517
Published: 2026
Container: Frontiers in oncology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1862517,
  title = {Academic anti CD19 CAR-T cell therapy for relapsed/refractory B-cell lymphomas in real-world clinical practice: a prospective cohort study.},
  author = {Konoplya NE and Doroshenko TM and Zharkova KY and Savich TV and Seviaryn IM and Bobrova NM and Beleevsky AA and Sarydze EK and Polyakov SL},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1862517},
  url = {https://doi.org/10.3389/fonc.2026.1862517}
}

RIS

TY  - JOUR
TI  - Academic anti CD19 CAR-T cell therapy for relapsed/refractory B-cell lymphomas in real-world clinical practice: a prospective cohort study.
AU  - Konoplya NE
AU  - Doroshenko TM
AU  - Zharkova KY
AU  - Savich TV
AU  - Seviaryn IM
AU  - Bobrova NM
AU  - Beleevsky AA
AU  - Sarydze EK
AU  - Polyakov SL
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1862517
UR  - https://doi.org/10.3389/fonc.2026.1862517
ER  -

APA

NE, K., TM, D., KY, Z., TV, S., IM, S., NM, B., AA, B., EK, S., & SL, P. (2026). Academic anti CD19 CAR-T cell therapy for relapsed/refractory B-cell lymphomas in real-world clinical practice: a prospective cohort study.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1862517

Source records

pubmed · retrieved 2026-09-26T23:31:54.365Z
europe-pmc · retrieved 2026-09-26T23:31:54.369Z
doaj · retrieved 2026-09-26T23:31:54.361Z